Related Experiment Video
Updated: Jan 20, 2026

Isolation of Mouse Primary Microglia by Magnetic-Activated Cell Sorting in Animal Models of Demyelination
Published on: April 5, 2022
Effect of sevoflurane treatment on microglia activation, NF-kB and MAPK activities
Xiangdi Yu1, Fangxiang Zhang1, Jinshan Shi1
1Department of Anesthesiology, Guizhou Provincial People's Hospital, Guiyang, China.
Abstract:
Microglia activation has been implicated in neurodegenerative disease. Sevoflurane is fluorinated methyl isopropyl ether with anti-inflammatory activity. In this study, we evaluated the potential effects of sevoflurane on lipopolysaccharides (LPS)-induced microglia activation. We treated primary microglia cells with sevoflurane prior to LPS treatment and tested the microglia migration, the productions of pro-inflammatory cytokines including tumor necrosis factor-α, interleukin-6 and interleukin-8. We also explored the effects of sevoflurane on NF-κB and p38 MAPK activation. Finally, we examined the effect of sevoflurane on cytokines production in rat brain. Sevoflurane significantly reduced LPS-induced microglial migration. Sevoflurane significantly decreased the production of pro-inflammatory cytokines both in vitro and in vivo. Sevoflurane attenuated activations of NF-κB and MAPK signaling pathways. Sevoflurane treatment decreased microglia activation by suppressing NF-kB and MAPK signaling pathways.
Insights
Sevoflurane, an anti-inflammatory agent, reduces microglia activation and pro-inflammatory cytokine production. This study shows sevoflurane suppresses NF-κB and MAPK pathways, offering potential therapeutic benefits for neurodegenerative diseases.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Microglia activation is a key factor in neurodegenerative diseases.
- Sevoflurane exhibits anti-inflammatory properties.
Purpose of the Study:
- To investigate the effects of sevoflurane on lipopolysaccharides (LPS)-induced microglia activation.
- To explore sevoflurane's impact on pro-inflammatory cytokine production and signaling pathways.
Main Methods:
- Primary microglia cells were treated with sevoflurane before LPS exposure.
- Microglia migration, cytokine production (TNF-α, IL-6, IL-8), and NF-κB/MAPK pathway activation were assessed.
- In vivo studies examined cytokine production in rat brains.
Main Results:
- Sevoflurane significantly reduced LPS-induced microglia migration.
- Pro-inflammatory cytokine production was decreased both in vitro and in vivo.
- Sevoflurane attenuated the activation of NF-κB and p38 MAPK signaling pathways.
Conclusions:
- Sevoflurane effectively suppresses microglia activation.
- The anti-inflammatory effects of sevoflurane are mediated through the inhibition of NF-κB and MAPK signaling pathways.
- Sevoflurane shows potential as a therapeutic agent for neurodegenerative conditions involving microglia activation.
Related Concept Videos
Co-activators and Co-repressors
tRNA Activation
tRNA Activation
Activation Energy
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
MAPK Signaling Cascades

